Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale

Clinical trial NCT02502149 · COMPLETED

Trial details

NCT number: NCT02502149
Sponsor: Bioverativ Therapeutics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2015-08-01
Primary completion: 2017-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.